AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $437 | $6,394 | $3,245 | $1,968 |
| % Growth | -93.2% | 97% | 64.9% | – |
| Cost of Goods Sold | $470 | $1,406 | $954 | $878 |
| Gross Profit | -$33 | $4,988 | $2,291 | $1,090 |
| % Margin | -7.6% | 78% | 70.6% | 55.4% |
| R&D Expenses | $1,612 | $3,590 | $1,923 | $2,407 |
| G&A Expenses | $27,039 | $19,953 | $13,509 | $10,287 |
| SG&A Expenses | $30,324 | $23,465 | $15,934 | $13,219 |
| Sales & Mktg Exp. | $3,285 | $3,512 | $2,425 | $2,932 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $31,936 | $27,055 | $17,857 | $15,626 |
| Operating Income | -$31,969 | -$22,067 | -$36,235 | -$14,536 |
| % Margin | -7,315.6% | -345.1% | -1,116.6% | -738.6% |
| Other Income/Exp. Net | -$488 | -$259 | $280 | -$454 |
| Pre-Tax Income | -$32,457 | -$22,326 | -$35,955 | -$14,990 |
| Tax Expense | -$144 | -$2,130 | -$2,040 | -$90 |
| Net Income | -$32,313 | -$20,196 | -$33,915 | -$14,900 |
| % Margin | -7,394.3% | -315.9% | -1,045.1% | -757.1% |
| EPS | -16.9 | -13.95 | -39.2 | -17.22 |
| % Growth | -21.1% | 64.4% | -127.6% | – |
| EPS Diluted | -16.9 | -13.95 | -39.2 | -17.22 |
| Weighted Avg Shares Out | 1,912 | 1,448 | 865 | 865 |
| Weighted Avg Shares Out Dil | 1,912 | 1,448 | 865 | 865 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $79 | $102 | $99 | $93 |
| Depreciation & Amortization | -$693 | $408 | $21,556 | -$363 |
| EBITDA | -$32,662 | -$21,659 | -$14,679 | -$14,899 |
| % Margin | -7,474.1% | -338.7% | -452.4% | -757.1% |